RecruitingAortic AneurysmAortic Aneurysm and DissectionAortic Diseases

A Study to Evaluate the Safety and Effectiveness of the Rapidlink Device When Used in Patients Undergoing an Open Surgical Procedure to Repair the Aorta

Eligible age

18+ yrs

Accepts

All genders

Locations

11 states

Healthy volunteers

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The Goal of this Clinical Study is to evaluate the safety and effectiveness of the Rapidlink device in the repair or replacement of the supra-aortic vessels during open surgical repair of aortic disease affecting the thoracic aorta. This study will collect information on patients who are already having surgery to repair their aorta and who will have Rapidlink device implanted into one or more of the aortic arch vessels. The first 32 subjects enrolled will undergo left subclavian artery repair or replacement, only, with the Rapidlink device. After the 32nd subject, enrollment will proceed to include subjects undergoing any supra-aortic vessel (i.e., left subclavian artery, left common carotid artery, and/or innominate artery) repair or replacement with the Rapidlink device in a planned surgery. After the 32nd subject is enrolled in the main group, up to 30 subjects will undergo supra-aortic vessel (i.e., left subclavian artery, left common carotid artery, and/or innominate artery) repair or replacement with the Rapidlink device in an emergency setting. Data will be collected before, during and after surgery including recovery at discharge, 30 days, 6 months, 1 and 2 years after the surgery.

Sponsor: Vascutek Ltd.

You may qualify if…

✓ Patient is aged 18 years or over on date of consent
✓ Written informed consent (from patient or a legally authorized representative) to participate in study, documenting willingness and ability to comply with all study procedures and study visits (unless an exemption for emergency cases has been IRB / EC approved)
✓ Patient's need for open surgical repair of the thoracic aorta using a Gelweave graft or a Thoraflex Hybrid device (AnteFlo or Plexus) in line with the applicable IFU
✓ Anticipated need to use Rapidlink for the repair or replacement of the LSA, LCCA and/or IA during the open surgical repair
✓ Patient has an 8-15 mm inner diameter (target SAV)
✓ The diameters of the patient's target supra-aortic vessel(s), fall within the ranges specified in the IFU

You may not qualify if…

✕ Patient does not have a clear landing zone equal to the implantable stent length which is free from stenosis, calcification or thrombus.
✕ Patient does not have a sealing zone free from tortuosity.
✕ Patient has significant angulation (\>79° with an internal radius of less than 6mm) for the full implantable stent length
✕ Patient cannot receive anticoagulation / antiplatelet therapy during or after the index procedure as per the protocol
✕ Patient has uncontrolled hypercoagulation
✕ Patient has a condition which may compromise or prevent the necessary imaging requirements
✕ Patient has anatomic variants which would compromise circulation to the first branch off the target artery after placement of the Rapidlink device (unless planned and/or otherwise revascularized)
✕ Patient is unfit for open surgical repair involving circulatory arrest per the study investigator